Multi-Cancer Early Detection Testing: The Oncologists' Perspective

Oncologists Tyler Kang, MD and Daniel Mackey, MD share their experiences bringing the Galleri test to community-based health systems and the impact it has had on their patients and practices.
Learn more:
www.galleri.com/
grail.com/
Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur.
Based on a clinical study of people ages 50 to 79, around 1% are expected to receive a Cancer Signal Detected result. After diagnostic evaluation, around 40% of these people are expected to have a confirmed cancer diagnosis. The overall sensitivity in study participants with lymphoma cancer was 74.8% (21.9% for stage I, 79.5% for stage II, 90.7% stage III, 95.2% stage IV).
Learn more and see Important Safety Information: www.galleri.com/